Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Ampersand Capital Partners
Sort By
Newest First
1 / 1
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01
Sep 07, 2022
mRNA Manufacturing
Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth
Vernal Biosciences
PR-M06-22-01-351
Jun 02, 2022
CDMO Acquisition
Vibalogics Acquired by Top Global CDMO Recipharm AB
Vibalogics
PR-M02-22-18
Feb 18, 2022
Investment
Investing at the Intersection of Industrial Manufacturing and Healthcare
David Q. Anderson
Ampersand Capital Partners
PAP-Q2-20-CL-025
Jul 01, 2020
Meet the Investor
Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider
David Q. Anderson
Ampersand Capital Partners
PAP-Q1-2019-CL-024
Mar 12, 2019
1 / 1
